Limitation of myocardial infarct size by metabolic interventions that reduce accumulation of fatty acid metabolites in ischemic myocardium
- 1 June 1986
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 111 (6) , 1048-1054
- https://doi.org/10.1016/0002-8703(86)90005-0
Abstract
No abstract availableThis publication has 31 references indexed in Scilit:
- Protection of the ischaemic dog heart by oxfenicineLife Sciences, 1981
- Importance of the source of hyaluronidase preparations in determining protective effect on ischemic heart muscle in acute myocardial infarctionAmerican Heart Journal, 1981
- Influence of free fatty acids on myocardial oxygen consumption and ischemic injuryThe American Journal of Cardiology, 1981
- Mechanism of action of oxfenicine on muscle metabolismBiochemical and Biophysical Research Communications, 1981
- Oxfenicine diverts rat muscle metabolism from fatty acid to carbohydrate oxidation and protects the ischaemic rat heartLife Sciences, 1980
- Inhibition of bovine heart Na+,K+-ATPase by palmitylcarnitine and palmityl-CoABiochemical and Biophysical Research Communications, 1977
- Effects of free fatty acid and enzyme release in experimental glucose on myocardial infarctionNature, 1975
- Uncoupling activity of long-chian fatty acidsBiochimica et Biophysica Acta, 1962
- The Effect of Nicotinic Acid on the Plasma Free Fatty Acids Demonstration of a Metabolic Type of SympathicolysisActa Medica Scandinavica, 1962
- Myorcardial Metabolism of Glucose, Lactic Acid, Amino Acids and Fatty Acids in Healthy Human Individuals at Rest and at Different Work LoadsScandinavian Journal of Clinical and Laboratory Investigation, 1961